These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38030142)

  • 1. Naturally Occurring Atherosclerosis Progression and In-stent Restenosis: Exploring Histomorphologic Associations Using Optical Coherence Tomography.
    Zhang W; Zhang W; Gu N; Qiu Z; Pan L; Zhao Y; Shi B
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):646-654. PubMed ID: 38030142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis.
    Zhang W; Zhang W; Deng Y; Gu N; Qiu Z; Deng C; Yang S; Pan L; Long S; Wang Y; Zhao Y; Shi B
    Int J Cardiol; 2024 Dec; 416():132451. PubMed ID: 39147280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation.
    Zhang DM; Chen SL
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):388-393. PubMed ID: 34029271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
    Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L; Mintz GS; Yin D; Yamamoto MH; Chin CY; Matsumura M; Fall K; Kirtane AJ; Parikh MA; Moses JW; Ali ZA; Shlofmitz RA; Maehara A
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study.
    Yuan X; Han Y; Hu X; Jiang M; Feng H; Fang Y; Liu M; Chen Y; Gao L
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):275-284. PubMed ID: 36315364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological characteristics of in-stent restenosis with different degrees of area stenosis: an optical coherence tomography study.
    Zhang W; Shen Y; Liu Z; Gu N; Rong J; Deng C; Wang X; Deng Y; Ma S; Yang S; Chen L; Hu X; Zhao Y; Zhao R; Shi B
    Int J Cardiovasc Imaging; 2024 Apr; 40(4):699-708. PubMed ID: 38416297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of LDL-C level with neoatherosclerosis and plaque vulnerability in patients with late restenosis: an optical coherence tomography study.
    Liu Z; Deng C; Zhao R; Xu G; Bai Z; Wang Z; Zhang W; Ma Y; Hu X; Jin C; Chen P; Ma S; Shi B
    Int J Cardiovasc Imaging; 2023 Dec; 39(12):2609-2619. PubMed ID: 37804387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of optical coherence tomography- and coronary angioscopy-assessed neointimal tissue characteristics on occurrence of periprocedural myonecrosis in patients with in-stent restenosis.
    Kimura S; Sugiyama T; Hishikari K; Nakamura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Sagawa Y; Kojima K; Ohtani H; Hikita H; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1483-94. PubMed ID: 27423209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
    Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Ibuki M; Hasegawa K; Ishibuchi K; Tamaru H; Yasuda S; Ishii R; Nakabayashi S; Kusumoto H; Higashino Y
    Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very early in-stent neoatherosclerosis assessed by optical coherence tomography.
    Vergara-Martel A; Pizzato PE; Dallan LAP; Pereira GTR; Richmond HCT; Attizzani GF; Jones MR
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1793-1794. PubMed ID: 31175526
    [No Abstract]   [Full Text] [Related]  

  • 20. [OCT analysis of in-stent neointima over 5 years post-DES implantation].
    Han Y; Yuan XH; Jiang MT; Feng HH; Zhang X; Zhang YQ; Jing J; Chen YD; Gao L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb; 52(2):150-157. PubMed ID: 38326066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.